Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Evolution Securities was a prominent UK-based investment bank and stockbroker that specialized in corporate finance, institutional equities, and research for mid-cap companies. While not a biotechnology company itself, it was a major player in the life sciences sector as a financial advisor and underwriter, helping numerous European biotech and healthcare firms raise capital and navigate public markets. The firm was particularly well-regarded for its specialist healthcare research team and its role in London-based IPOs. In late 2011, Evolution Securities was acquired by the international specialist bank Investec to strengthen its investment banking and securities operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Evolution Securities.